You are here

Article Text

Article menu
Download PDFPDF
Socrates
SOCRATES 10 (synopsis of Cochrane reviews applicable to emergency services)
  1. P Gilligan1,
  2. J Jones1,
  3. A Khan1,
  4. D Hegarty2,
  5. M Shepherd1,
  6. G Lumsden1,
  7. G Kitching1,
  8. A Taylor1,
  9. H Law1,
  10. J Brenchley1
  1. 1Specialist Registrars in Emergency Medicine on The Yorkshire Rotation, UK
  2. 2General Practitioner, Leeds, UK
  1. Correspondence to:
 Dr P Gilligan
 1 Far Moss, Alwoodley, Leeds LS17 7NU, UK; hegartydeirdreireland.com

https://doi.org/10.1136/emj.2004.019968

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    In this, the tenth article of the SOCRATES series, we present our synopses of reviews from the Cochrane Database of Systematic Reviews relating to gastroenterology and fluid management that the working party felt were of particular relevance to emergency medicine practitioners. The methods of our review and the rationale for the forming the SOCRATES working party are as have previously been published.

    HUMAN ALBUMIN SOLUTION FOR RESUSCITATION AND VOLUME EXPANSION IN CRITICALLY ILL PATIENTS

    Background

    The objective of this review was to quantify the effect on mortality of human albumin and plasma protein fraction in the management of critically ill patients.

    Results

    A total of 30 randomised controlled trials were identified. In each of the patient categories the risk of death in the albumin treated group was higher than in the placebo group. There were 156 deaths among the 1419 patients. Overall the risk of death in patients treated with albumin is 6% (95% CI 3% to 9%) higher than in patients not given albumin.

    SOCRATES says

    There is no evidence that albumin reduces mortality and a strong …

    View Full Text

    Footnotes

    • Funding: none.

    • Competing interests: none declared